• No results found

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency

N/A
N/A
Protected

Academic year: 2020

Share "Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Patients’ characteristics
Table 2 Top dysregulated mRNA comparisons in peripheral blood mononuclear cells from severe vs mild aaTD emphysema patients
Table 4 Kegg functional enrichment analysis of the Degs between peripheral blood mononuclear cells isolated from severe vs mild aaTD emphysema patients
Table 6 miRNA–target interactions between differentially expressed mirnas and mrna in severe vs mild aaTD emphy-sema patients
+2

References

Related documents

Laboratory-scale furrow results compared with field test results highlighting the effect of molecular weight on the effectiveness of polyacrylamide, PAM, in controlling

Low photosynthetic rate (as determined by CO. fixation rate and RuBP carboxylase enzyme) and low nitrate metabolism particularly at the time of seed filling are partly

The cross tab shows that 26 out of 40 employees of MUET and 18 out of 40 employees of LUMHS and 22 out of 40 employees of SINDH University are agree at their personal

Instead, they combine to provide a general outline of acceptable State action, sometimes by analogy (such as the effort to extend neutrality principles to the inapposite

an adhesive resin with self-adhering flowable composite resin would significantly increase dentin bond strength and reduce microleakage to both enamel and dentin, others

S Dhami: support to co‑ordinate the undertaking of the systematic review; U Nurmatov: support to undertake the review; I Agache: none; S Lau: grant from Allergopharma; drug

However, it is clear from the prepon- derance of senior EM physicians present during the weekday day shift, with no EM specialists present over- night, and none in smaller

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with